Literature DB >> 22596271

Distinct functional activity of the precuneus and posterior cingulate cortex during encoding in the preclinical stage of Alzheimer's disease.

Lorena Rami1, Roser Sala-Llonch, Cristina Solé-Padullés, Juan Fortea, Jaume Olives, Albert Lladó, Cleofe Peña-Gómez, Mircea Balasa, Bea Bosch, Anna Antonell, Raquel Sanchez-Valle, David Bartrés-Faz, Jose L Molinuevo.   

Abstract

In this study functional magnetic resonance imaging (fMRI) is used to investigate the functional brain activation pattern in the preclinical stage of AD (pre-AD) subjects during a visual encoding memory task. Thirty subjects, eleven in the pre-AD stage, with decreased cerebrospinal fluid levels of Aβ42 (<500 pg/ml), and 19 controls with normal Aβ42 levels (CTR) were included. fMRI was acquired during a visual encoding task. Data were analyzed through an Independent Component Analysis (ICA) and region-of-interest-based univariate analysis of task-related BOLD signal change. From the ICA decomposition, we identified the main task-related component, which included the activation of visual associative areas and prefrontal executive regions, and the deactivation of the default-mode network. The activation was positively correlated with task performance in the CTR group (p < 0.0054). Within this pattern, subjects in the pre-AD stage had significantly greater activation of the precuneus and posterior cingulate cortex during encoding. Subjects in the pre-AD stage present distinct functional neural activity before the appearance of clinical symptomatology. These findings may represent that subtle changes in functional brain activity precede clinical and cognitive symptoms in the AD continuum. Present findings provide evidence suggesting that fMRI may be a suitable biomarker of preclinical AD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22596271     DOI: 10.3233/JAD-2012-120223

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  19 in total

1.  Flexible modulation of network connectivity related to cognition in Alzheimer's disease.

Authors:  Donald G McLaren; Reisa A Sperling; Alireza Atri
Journal:  Neuroimage       Date:  2014-05-20       Impact factor: 6.556

Review 2.  Neuroimaging and other biomarkers for Alzheimer's disease: the changing landscape of early detection.

Authors:  Shannon L Risacher; Andrew J Saykin
Journal:  Annu Rev Clin Psychol       Date:  2013-01-07       Impact factor: 18.561

3.  Synaptic change in the posterior cingulate gyrus in the progression of Alzheimer's disease.

Authors:  Stephen W Scheff; Douglas A Price; Mubeen A Ansari; Kelly N Roberts; Frederick A Schmitt; Milos D Ikonomovic; Elliott J Mufson
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

4.  Uncovering complex central autonomic networks at rest: a functional magnetic resonance imaging study on complex cardiovascular oscillations.

Authors:  Gaetano Valenza; Luca Passamonti; Andrea Duggento; Nicola Toschi; Riccardo Barbieri
Journal:  J R Soc Interface       Date:  2020-03-18       Impact factor: 4.118

Review 5.  The evolution of preclinical Alzheimer's disease: implications for prevention trials.

Authors:  Reisa Sperling; Elizabeth Mormino; Keith Johnson
Journal:  Neuron       Date:  2014-11-05       Impact factor: 17.173

Review 6.  Neuroimaging biomarkers of neurodegenerative diseases and dementia.

Authors:  Shannon L Risacher; Andrew J Saykin
Journal:  Semin Neurol       Date:  2013-11-14       Impact factor: 3.420

7.  Amyloid burden, neuronal function, and cognitive decline in middle-aged adults at risk for Alzheimer's disease.

Authors:  Ozioma C Okonkwo; Jennifer M Oh; Rebecca Koscik; Erin Jonaitis; Caitlin A Cleary; N Maritza Dowling; Barbara B Bendlin; Asenath Larue; Bruce P Hermann; Todd E Barnhart; Dhanabalan Murali; Howard A Rowley; Cynthia M Carlsson; Catherine L Gallagher; Sanjay Asthana; Mark A Sager; Brad T Christian; Sterling C Johnson
Journal:  J Int Neuropsychol Soc       Date:  2014-03-12       Impact factor: 2.892

8.  Voxel-based meta-analysis of grey matter changes in Alzheimer's disease.

Authors:  Wen-Ying Wang; Jin-Tai Yu; Yong Liu; Rui-Hua Yin; Hui-Fu Wang; Jun Wang; Lin Tan; Joaquim Radua; Lan Tan
Journal:  Transl Neurodegener       Date:  2015-03-27       Impact factor: 8.014

Review 9.  Neuroimaging in aging and neurologic diseases.

Authors:  Shannon L Risacher; Andrew J Saykin
Journal:  Handb Clin Neurol       Date:  2019

10.  APOE status modulates the changes in network connectivity induced by brain stimulation in non-demented elders.

Authors:  Cleofé Peña-Gomez; Cristina Solé-Padullés; Imma C Clemente; Carme Junqué; Núria Bargalló; Beatriz Bosch; José Luis Molinuevo; Josep Valls-Solé; Alvaro Pascual-Leone; David Bartrés-Faz
Journal:  PLoS One       Date:  2012-12-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.